Johan Seijsing

Improved Biodistribution and Extended Serum Half-Life of a Bacteriophage Endolysin by Albumin Binding Domain Fusion

Johan Seijsing, Anna M. Sobieraj, Nadia Keller et al. · Frontiers in Microbiology · 2018 · 59 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +15

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein

Johan Seijsing, Malin Lindborg, Ingmarie Höidén‐Guthenberg et al. · Proceedings of the National Academy of Sciences · 2014 · 54 citations · Full text

Pharmacy, Biochemistry, Pharmacology +16

In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor

Johan Seijsing, Shengze Yu, Fredrik Y. Frejd et al. · Scientific Reports · 2018 · 47 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Bioactive Silk Coatings Reduce the Adhesion of <i>Staphylococcus aureus</i> while Supporting Growth of Osteoblast-like Cells

Linnea Nilebäck, Mona Widhe, Johan Seijsing et al. · ACS Applied Materials & Interfaces · 2019 · 33 citations · Full text

Natural Sciences, Bioengineering, Biotechnology +17

Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain

Hao Liu, Johan Seijsing, Fredrik Y. Frejd et al. · International Journal of Oncology · 2015 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15